Insider trading

Period: 120 months Stock: MRK + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

159 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

159 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

159 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

159 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
159 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
159 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

159 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
7 May 2020
BRUN LESLIE A Director
Sold, plan not stated
$377.30K 5,000 at 75.46
72.0%
Sold half or more
13 Jan 2020
Gerberding Julie L. EVP Strat Comm, GI Pub Policy
Sold, plan not stated
$9.12M 102,073 at 89.34
73.4%
Sold half or more
9 Aug 2019
DeLuca Richard R. EVP&Pres, Merck Animal Heallth
Sold, plan not stated
$546.85K 6,427 at 85.09
8.2%
8 Aug 2019
DeLuca Richard R. EVP&Pres, Merck Animal Heallth
Sold, plan not stated
$2.69M 31,699 at 85.01
30.7%
25 Jun 2019
Davis Robert M EVP, Global Svcs & CFO
Sold, plan not stated 2×
$18.51M 216,718 at 85.43
61.2%
Sold half or more
7 May 2019
Clyburn Frank EVP, Chief Commercial Officer
Sold, plan not stated
$1.94M 25,000 at 77.73
27.0%
3 May 2019
DeLuca Richard R. EVP&Pres, Merck Animal Heallth
Sold, plan not stated
$2.80M 35,000 at 80.00
33.0%
25 Mar 2019
Davis Robert M EVP, Global Svcs & CFO
Sold, plan not stated
$15.86M 192,572 at 82.38
58.3%
Sold half or more
20 Mar 2019
FRAZIER KENNETH C Chairman, President & CEO
Sold, plan not stated
$15.81M 192,736 at 82.05
19.5%
13 Mar 2019
FRAZIER KENNETH C Chairman, President & CEO
Sold, plan not stated
$1.54M 18,725 at 82.00
2.3%
5 Mar 2019
FRAZIER KENNETH C Chairman, President & CEO
Sold, plan not stated
$570.81K 6,961 at 82.00
0.9%
4 Mar 2019
FRAZIER KENNETH C Chairman, President & CEO
Sold, plan not stated
$1.08M 13,144 at 82.01
1.6%
22 Feb 2019
FRAZIER KENNETH C Chairman, President & CEO
Sold, plan not stated
$4.32M 53,961 at 80.02
7.2%
21 Feb 2019
FRAZIER KENNETH C Chairman, President & CEO
Sold, plan not stated
$3.36M 41,992 at 80.00
5.7%
19 Feb 2019
FRAZIER KENNETH C Chairman, President & CEO
Sold, plan not stated
$3.42M 42,700 at 80.02
5.8%
15 Feb 2019
FRAZIER KENNETH C Chairman, President & CEO
Sold, plan not stated
$7.44M 92,913 at 80.03
11.8%
14 Feb 2019
Karachun Rita A Sr. VP Fince-Global Controller
Sold, plan not stated
$5.11M 64,662 at 78.96
80.0%
Sold half or more
13 Feb 2019
WEEKS WENDELL P Director
Sold, plan not stated
$393.55K 5,000 at 78.71
98.0%
Sold half or more
12 Feb 2019
Chattopadhyay Sanat Exe V-P & Pres. MMD
Sold, plan not stated
$5.80M 73,727 at 78.62
58.9%
Sold half or more
8 Feb 2019
BRUN LESLIE A Director
Sold, plan not stated
$235.68K 3,052 at 77.22
61.0%
Sold half or more
5 Feb 2019
FRAZIER KENNETH C Chairman, President & CEO
Sold, plan not stated
$18.08M 231,566 at 78.08
25.1%
4 Feb 2019
GLOCER THOMAS H Director
Sold, plan not stated
$759.59K 10,000 at 75.96
66.2%
Sold half or more
8 Nov 2018
PERLMUTTER ROGER M Exe V-P & Pres, MRL
Sold, plan not stated
$16.97M 225,443 at 75.27
61.4%
Sold half or more
7 Nov 2018
Gerberding Julie L. EVP Strat Comm, Gl Pub Policy
Sold, plan not stated
$2.72M 36,218 at 75.14
43.9%
1 Nov 2018
Schechter Adam H EVP & Pres-Global Human Health
Sold, plan not stated 2×
$20.51M 277,879 at 73.81
100%
Sold half or more
31 Oct 2018
Watson Ashley SVP Chief Ethics & Com Officer
Sold, plan not stated
$3.50M 47,036 at 74.33
82.8%
Sold half or more
30 Oct 2018
DeLuca Richard R. EVP&Pres, Merck Animal Health
Sold, plan not stated
$1.83M 25,467 at 72.00
31.0%
2 Oct 2018
FRAZIER KENNETH C Chairman, President & CEO
Sold, plan not stated
$20.17M 279,850 at 72.07
28.8%
18 Sep 2018
FRAZIER KENNETH C Chairman, President & CEO
Sold, plan not stated
$19.61M 279,851 at 70.08
28.8%
17 Sep 2018
Schechter Adam H EVP & Pres-Global Human Health
Sold, plan not stated
$7.02M 100,000 at 70.18
100%
Sold half or more
17 Sep 2018
Schechter Adam H EVP & Pres-Global Human Health · indirect
Sold, plan not stated
$516.51K 7,360 at 70.18
11.7%
3 Aug 2018
Chattopadhyay Sanat Exe V-P & Pres. MMD
Sold, plan not stated
$1.90M 29,208 at 65.20
36.2%
2 Aug 2018
Karachun Rita A Sr. VP Fince-Global Controller
Sold, plan not stated
$325.04K 5,000 at 65.01
23.6%
31 Jul 2018
FRAZIER KENNETH C Chairman, President & CEO
Sold, plan not stated
$14.83M 228,091 at 65.00
24.3%
18 Jun 2018
Schechter Adam H EVP & Pres-Global Human Health
Sold, plan not stated
$6.10M 100,000 at 61.00
100%
Sold half or more
18 Jun 2018
Schechter Adam H EVP & Pres-Global Human Health · indirect
Sold, plan not stated
$2.08M 34,094 at 61.00
35.2%
15 May 2018
Gerberding Julie L. EVP Strat Comm, Gl Pub Policy
Sold, plan not stated
$594.96K 9,972 at 59.66
17.9%
16 Apr 2018
Sold, plan not stated
$1.39M 24,000 at 58.00
23.0%
9 Feb 2018
WEEKS WENDELL P Director
Sold, plan not stated
$267.83K 5,000 at 53.57
98.0%
Sold half or more
16 Jan 2018
Sold, plan not stated 2×
$3.70M 60,000 at 61.63
39.1%
16 Jan 2018
Schechter Adam H EVP & Pres-Global Human Health
Sold, plan not stated
$3.14M 50,994 at 61.63
100%
Sold half or more
16 Jan 2018
Schechter Adam H EVP & Pres-Global Human Health · indirect
Sold, plan not stated
$3.12M 50,608 at 61.63
44.6%
16 Jan 2018
Holston Michael J EVP, General Counsel
Sold, plan not stated
$770.38K 12,500 at 61.63
20.3%
12 Jan 2018
Sold, plan not stated
$290.00K 5,000 at 58.00
4.7%
8 Nov 2017
GLOCER THOMAS H Director
Sold, plan not stated
$280.98K 5,000 at 56.20
49.5%
12 May 2017
KIDDER C ROBERT Director
Sold, plan not stated
$317.70K 5,000 at 63.54
34.9%
3 Apr 2017
Schechter Adam H EVP & Pres-Global Human Health · indirect
Sold, plan not stated
$3.42M 53,850 at 63.48
31.6%
14 Feb 2017
Karachun Rita A Sr. VP Fince-Global Controller
Sold, plan not stated
$191.23K 2,954 at 64.73
20.2%
8 Feb 2017
RUSSO PATRICIA F Director
Sold, plan not stated
$322.12K 5,000 at 64.42
27.6%
6 Feb 2017
WEEKS WENDELL P Director
Sold, plan not stated
$322.54K 5,000 at 64.51
98.0%
Sold half or more
Showing 101–150 of 159. ← Newer Page 3 of 4 Older →